KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $546,000 | -9.6% | 160,600 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $604,000 | -8.1% | 160,600 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $657,000 | -0.6% | 160,600 | +13.0% | 0.00% | 0.0% |
Q4 2017 | $661,000 | -28.7% | 142,100 | +8.9% | 0.00% | 0.0% |
Q3 2017 | $927,000 | -1.8% | 130,500 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $944,000 | +17.4% | 130,500 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $804,000 | +5.1% | 130,500 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $765,000 | -0.9% | 130,500 | -10.2% | 0.00% | 0.0% |
Q3 2016 | $772,000 | -19.8% | 145,400 | 0.0% | 0.00% | -50.0% |
Q2 2016 | $963,000 | +21.1% | 145,400 | -17.4% | 0.00% | +100.0% |
Q1 2016 | $795,000 | +9.2% | 176,100 | +22.1% | 0.00% | -50.0% |
Q4 2015 | $728,000 | +43.3% | 144,200 | 0.0% | 0.00% | +100.0% |
Q3 2015 | $508,000 | -59.9% | 144,200 | +13.6% | 0.00% | -66.7% |
Q2 2015 | $1,266,000 | -9.9% | 126,900 | +14.9% | 0.00% | -25.0% |
Q1 2015 | $1,405,000 | +0.1% | 110,400 | +11.3% | 0.00% | -20.0% |
Q4 2014 | $1,404,000 | +5.2% | 99,200 | +2.3% | 0.01% | 0.0% |
Q3 2014 | $1,334,000 | -10.6% | 97,000 | 0.0% | 0.01% | -16.7% |
Q2 2014 | $1,492,000 | -9.7% | 97,000 | 0.0% | 0.01% | 0.0% |
Q1 2014 | $1,653,000 | +82.7% | 97,000 | +38.8% | 0.01% | +50.0% |
Q4 2013 | $905,000 | +28.2% | 69,900 | 0.0% | 0.00% | +33.3% |
Q3 2013 | $706,000 | +28.1% | 69,900 | -5.3% | 0.00% | +50.0% |
Q2 2013 | $551,000 | – | 73,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |